Johnson & Johnson (JNJ) Net Income (QoQ) (2009 - 2026)
Johnson & Johnson (JNJ) Net Income (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Novartis Ag | 112.59 Bn | 111.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 2.33% |
| Dec 28, 2025 | -0.70% |
| Sep 28, 2025 | -6.95% |
| Jun 29, 2025 | -49.66% |
| Dec 31, 2023 | -100.38% |
| Oct 1, 2023 | 9,461.64% |
| Jul 2, 2023 | -154.85% |
| Apr 2, 2023 | 44.37% |
| Jan 1, 2023 | 97.97% |
| Oct 2, 2022 | -73.19% |
| Jul 3, 2022 | -4.50% |
| Oct 3, 2021 | -41.59% |
| Jul 4, 2021 | 1.31% |
| Apr 4, 2021 | 256.56% |
| Jan 3, 2021 | -51.10% |
| Sep 27, 2020 | -1.99% |
| Jun 28, 2020 | -37.44% |
| Mar 29, 2020 | 44.54% |
| Dec 29, 2019 | 128.75% |
| Sep 29, 2019 | -68.74% |